Newsroom · Sioux Falls

The 2026 Part D $2,100 Drug Cost Cap Explained for Sioux Falls Medicare Beneficiaries

How the new out-of-pocket ceiling changes drug cost planning — and what to check in the local plan landscape before you enroll.

Big Sioux Benefits Data Desk

Published June 18, 2026 · 9 min read · Sourced from CMS.gov

The 2026 Medicare Part D out-of-pocket cap is the most consumer-friendly change to the drug program since it launched in 2006. For the first time, there's a hard ceiling — $2,100 — on what you pay out-of-pocket for covered drugs in a calendar year. After that point, your plan covers 100% for the rest of the year.

Every figure in this article comes from public federal sources: the CMS PY2026 Medicare plan landscape, CMS 2026 star ratings, and CDC PLACES 2023 county health data. No numbers invented; every claim sourced.

What the $2,100 cap actually means — and what changed

Before 2026, Part D had four phases: a deductible, an initial coverage period, a coverage gap (the "donut hole"), and then a catastrophic phase — where you still owed 5% of very high drug costs with no upper limit. The Inflation Reduction Act eliminated that catastrophic coinsurance entirely and replaced the whole structure with a clean annual ceiling.

The cap counts your deductible, copays, and coinsurance — all your actual out-of-pocket drug costs. It does not count your monthly Part D premium toward that $2,100 total. And it resets every January 1.

The three phases of 2026 Part D coverage

The structure is simpler than it used to be. Here's how it works in 2026:

Source: CMS Medicare Advantage / Part D Landscape (PY2026) — 2026 Part D cost rails.

The practical difference: in 2025, a beneficiary spending $10,000 on specialty drugs still owed 5% of the catastrophic-phase amount with no ceiling. In 2026, their out-of-pocket stops at $2,100 — period. If your drug list is expensive, the cap is the most important number on your plan comparison sheet.

Who benefits most — the Sioux Falls chronic condition picture

The cap matters most for people on costly prescriptions. That includes anyone managing chronic conditions — and Minnehaha County carries a significant chronic-condition burden, per CDC PLACES 2023 data:

Source: CDC PLACES: Local Data for Better Health, County 2023 (2023, model-based estimates for adults in Minnehaha County).

Nearly one in three Sioux Falls adults has high blood pressure (31.7%). One in ten has diagnosed diabetes (10%). Cancer prevalence stands at 8%. These conditions often require brand-name or specialty medications that, before 2026, could push annual drug spending far above any predictable ceiling.

If you manage hypertension with a standard generic, the cap may reassure you but never come into play. If you're on a biologic, an oncology drug, or a specialty diabetes medication, the cap is likely to become a real financial backstop — possibly in the first quarter of the year.

The Sioux Falls drug plan landscape for 2026

Minnehaha County has 15 plans that include Part D drug coverage for 2026. Here's the breakdown by plan type, including who can enroll and how drug coverage works in each:

Source: CMS Medicare Advantage / Part D Landscape (PY2026), Minnehaha County, PY2026.

If you're on Original Medicare + Medigap, you add a stand-alone PDP separately — choose from the 11 plans available statewide. If you chose Medicare Advantage, drug coverage is bundled. Either way, the $2,100 cap applies — but the formulary, tiers, and pharmacy network are plan-specific and determine how fast you reach the ceiling.

The 5 MA PPOs — drug deductibles compared

For the 5 standard Medicare Advantage PPOs open to any Sioux Falls beneficiary in 2026, the drug deductible is the first expense that counts toward your $2,100 cap:

Source: CMS Medicare Advantage / Part D Landscape (PY2026) & CMS Medicare Advantage & Part D Star Ratings (2026), Minnehaha County, PY2026.

Two things jump out. First, Sanford's Align ChoicePlus ($0 premium) carries a $350 drug deductible — $265 below the standard $615 ceiling — and Align ChoiceElite sets a $300 deductible. Both are Sanford-network plans. Second, all five plans sit at 3.5★ CMS, so the deductible — not the star rating — becomes the primary differentiator when comparing drug costs. A lower deductible means you reach your copay/coinsurance phase sooner, which matters if your formulary tier keeps those copays low.

Formulary tiers — the new deciding factor

Before the cap, choosing the lowest-premium plan was a reasonable shortcut. Now that there's a ceiling, the formulary tier of your specific drugs is the deciding factor. Here's how the tier structure typically works:

• Tier 1 — Preferred generic: lowest copays, often $0–$5. Spending accumulates slowly toward the cap.
• Tier 2 — Generic: still low, but slightly higher than Tier 1.
• Tier 3 — Preferred brand: coinsurance climbs. You approach the cap faster.
• Tier 4 — Non-preferred brand: higher coinsurance; brand drugs your plan prefers less.
• Tier 5 — Specialty: highest coinsurance — often 25–33% of the drug's cost. A single specialty drug can push you to the $2,100 cap within the first few months of the year.

The strategic move: before AEP or when first enrolling, look up your exact drug names in each plan's online formulary tool — available at CMS or each plan's website — and compare tier placements across your options. A plan with a slightly higher premium may place your specialty drug at Tier 3 instead of Tier 5, saving far more than the premium difference before you hit the cap.

IRMAA and Part D — the income cost layer

One cost the $2,100 cap does not cover: the IRMAA surcharge. If your modified adjusted gross income (MAGI) from two years prior exceeds certain thresholds set by CMS, Medicare adds an Income-Related Monthly Adjustment Amount to your Part D premium. This surcharge is billed separately by Medicare — not by the plan — and does not count toward your $2,100 out-of-pocket cap.

IRMAA affects a minority of beneficiaries — typically those with higher retirement income, investment distributions, or a one-time income event (such as a property sale or Roth IRA conversion) that elevated MAGI in the reference year. If you think your income may be near a threshold, check with CMS or a licensed agent before finalizing your plan. You can also appeal an IRMAA determination if a qualifying life event — retirement, divorce, or death of a spouse — reduced your income after the reference year.

What to watch in 2026

1. Run your drug list through every plan's formulary tool — compare tier placement, copay or coinsurance, quantity limits, and prior-authorization requirements for your specific medications. Do this before AEP closes December 7.
2. Compare drug deductibles alongside the premium — in Sioux Falls, deductibles range from lower amounts on certain Sanford plans to the $615 standard maximum. A lower deductible can be a meaningful saving if you're on expensive drugs.
3. Watch for mid-year formulary changes — plans can move drugs to different tiers at plan-year renewal. Read your Annual Notice of Change (ANOC) each fall and act during AEP if your drug's tier worsens.
4. Check your preferred pharmacy's network status — preferred pharmacy networks affect your drug copays. Confirm your usual pharmacy is in each plan's preferred network; switching to a preferred pharmacy can reduce your per-fill costs.
5. Model any large income event before year-end if IRMAA is a concern — a Roth conversion, capital-gain realization, or required minimum distribution spike in one year can trigger two years of IRMAA surcharges. Plan with a tax advisor if applicable.

How we know all this: Big Sioux Benefits runs every article through a data desk that cross-references the CMS PY2026 plan landscape, 2026 Part D cost rails, Minnehaha County enrollment, CMS star ratings, and CDC PLACES county health data — built by Strategic AI Architects. Every figure here is from a public federal dataset. This is education, not advice; confirm your plan, costs, and eligibility with a licensed agent or CMS. We take no payment from any carrier to feature a plan.